Effectivity of Nd Yag PI in treatment of acute primary angle closure glaucoma

Insights

Nd Yag Peripheral Iridotomy (PI) effectively treated acute primary angle closure glaucoma in 78% of patients, significantly reducing intraocular pressure (IOP) and improving visual acuity. Factors like prolonged attacks and high initial IOP indicated potential treatment failure.

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Surgical Efficacy Studies

Background:

  • Acute primary angle closure glaucoma (AACG) is a serious condition requiring prompt treatment.
  • Nd Yag Peripheral Iridotomy (PI) is a common intervention for AACG.
  • Understanding the efficacy of PI in diverse patient populations is crucial for clinical practice.

Purpose of the Study:

  • To evaluate the efficacy of Nd Yag Peripheral Iridotomy (PI) in treating acute primary angle closure glaucoma (AACG).
  • To identify factors associated with successful PI treatment and treatment failure in AACG patients.

Main Methods:

  • A prospective hospital-based study conducted in Nepal Eye Hospital.
  • Included 50 patients diagnosed with acute primary angle closure glaucoma (AACG).
  • Excluded patients with secondary angle closure glaucoma.

Main Results:

  • 78% of eyes achieved controlled intraocular pressure (IOP) after Nd Yag PI.
  • Mean visual acuity improved from presenting levels (e.g., 1/60-PL) to 6/60 at discharge.
  • Mean IOP decreased significantly to 12 mmHg post-procedure.
  • Factors like prolonged attack duration, elderly age, and very high presenting IOP were linked to PI failure.

Conclusions:

  • Nd Yag Peripheral Iridotomy (PI) is an effective treatment for a majority of acute primary angle closure glaucoma (AACG) cases.
  • Early intervention and appropriate patient selection are key to successful PI outcomes.
  • Further research may explore management strategies for cases with risk factors for PI failure.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
251